WebFinal Approved Package Insert–20 March 2024 Page 2of 23 The pharmacodynamic effects of apixaban are reflective of the mechanism of action. As a result of FXa inhibition, apixabanprolongs clotting tests such as prothrombin time (PT),international normalised ratio (INR)and activated partial thromboplastin time (aPTT). WebThe list is arranged alphabetically by the proper name of the product (s). Information is provided for original product approvals, new indications, and the current package insert. …
FDA Product Approval: View All - immunize.org
Spherusol ® is administered as a 0.1 mL dose by intradermal injection to the volar surface of the forearm using a tuberculin syringe (0.5 or 1.0 mL) and a ½ inch 26-27 gauge needle. The needle should be inserted bevel side up in the skin at a 15-20 degree angle. See more Spherusol ® is a skin test antigen indicated for the detection of delayed-type hypersensitivity to Coccidioides immitis in individuals with a history of pulmonary coccidioidomycosis. Spherusol ®is approved for use in … See more 2.1 Preparation for Administration Spherusol ®is a clear, colorless sterile solution for intradermal administration. Parenteral drug products should be inspected visually for particulate matter and discoloration … See more A severe allergic reaction (e.g., anaphylaxis) to Spherusol ®, or any component of Spherusol ®or other coccidioidin products … See more Spherusol ® is a solution for intradermal injection supplied in a 1 mL multi-dose vial. Each 0.1 mL dose contains 1.27 mcg of spherule-derived Coccidioides immitisantigen. See more WebDocument Library - Siemens Healthineers caffeine water
DailyMed - SPHERUSOL- coccidioides immitis spherule
WebJun 23, 2024 · Packaging of pharmaceutical medications may vary depending on the use and type of substance packaged: prescription drugs, non-prescription (over-the-counter) drugs, and herbals and dietary … WebApr 9, 2015 · SPHERUSOL is a skin test antigen indicated for the detection of delayed-type hypersensitivity to Coccidioides in individuals with a history of pulmonary coccidioidomycosis. Until now, clinicians... Web3 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Melanoma KEYTRUDA® (pembrolizumab) is indicated for the treatment of patients with unresectable or metastatic melanoma. 1.2 Non-Small Cell Lung Cancer KEYTRUDA, in combination with pemetrexed and platinum chemotherapy, is indicated for the first-line cmslaser.com